Does the media favor CNMD or MMSI?

In the previous week, CONMED had 4 more articles in the media than Merit Medical Systems. MarketBeat recorded 9 mentions for CONMED and 5 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.01 beat CONMED's score of 0.17 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Merit Medical Systems 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, LIVN or CNMD?

CONMED has lower revenue, but higher earnings than LivaNova. CONMED is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LivaNova $1.39B 3.18 -$242.47M $1.95 41.26 CONMED $1.37B 0.96 $47.06M $1.77 24.65

Is LIVN or CNMD more profitable?

LivaNova has a net margin of 7.48% compared to CONMED's net margin of 4.00%. LivaNova's return on equity of 16.48% beat CONMED's return on equity. Company Net Margins Return on Equity Return on Assets LivaNova 7.48% 16.48% 7.59% CONMED 4.00% 13.84% 6.05%

Does the media favor LIVN or CNMD?

In the previous week, CONMED had 8 more articles in the media than LivaNova. MarketBeat recorded 9 mentions for CONMED and 1 mentions for LivaNova. LivaNova's average media sentiment score of 0.72 beat CONMED's score of 0.17 indicating that LivaNova is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CONMED 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor CNMD or MMED?

In the previous week, MiniMed Group had 4 more articles in the media than CONMED. MarketBeat recorded 13 mentions for MiniMed Group and 9 mentions for CONMED. CONMED's average media sentiment score of 0.17 beat MiniMed Group's score of 0.15 indicating that CONMED is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 12 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings & valuation, NVST or CNMD?

CONMED has lower revenue, but higher earnings than Envista. CONMED is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Envista $2.72B 1.60 $47M $0.41 65.33 CONMED $1.37B 0.96 $47.06M $1.77 24.65

Is NVST or CNMD more profitable?

CONMED has a net margin of 4.00% compared to Envista's net margin of 2.41%. CONMED's return on equity of 13.84% beat Envista's return on equity. Company Net Margins Return on Equity Return on Assets Envista 2.41% 7.11% 3.91% CONMED 4.00% 13.84% 6.05%

Does the media favor NVST or CNMD?

In the previous week, CONMED had 8 more articles in the media than Envista. MarketBeat recorded 9 mentions for CONMED and 1 mentions for Envista. Envista's average media sentiment score of 1.02 beat CONMED's score of 0.17 indicating that Envista is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envista 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CONMED 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer IRTC or CNMD?

In the previous week, iRhythm Technologies had 1 more articles in the media than CONMED. MarketBeat recorded 10 mentions for iRhythm Technologies and 9 mentions for CONMED. iRhythm Technologies' average media sentiment score of 0.27 beat CONMED's score of 0.17 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 2 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral CONMED 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

CONMED (CNMD) Competitors

$43.64 +0.44 (+1.02%)

As of 12:18 PM Eastern

Compare

CNMD vs. MMSI, LIVN, MMED, NVST, and IRTC

Should you buy CONMED stock or one of its competitors? MarketBeat compares CONMED with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CONMED include Merit Medical Systems (MMSI), LivaNova (LIVN), MiniMed Group (MMED), Envista (NVST), and iRhythm Technologies (IRTC).

How does CONMED compare to Merit Medical Systems?

CONMED (NYSE:CNMD) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, media sentiment, earnings and dividends.

Merit Medical Systems has a net margin of 9.03% compared to CONMED's net margin of 4.00%. CONMED's return on equity of 13.84% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	4.00%	13.84%	6.05%
Merit Medical Systems	9.03%	13.54%	7.94%

CONMED presently has a consensus target price of $38.80, suggesting a potential downside of 11.09%. Merit Medical Systems has a consensus target price of $92.80, suggesting a potential upside of 23.19%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, analysts plainly believe Merit Medical Systems is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.63
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64

99.7% of Merit Medical Systems shares are owned by institutional investors. 0.3% of CONMED shares are owned by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

CONMED has a beta of 0.93, suggesting that its share price is 7% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market.

In the previous week, CONMED had 4 more articles in the media than Merit Medical Systems. MarketBeat recorded 9 mentions for CONMED and 5 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.01 beat CONMED's score of 0.17 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Merit Medical Systems	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Merit Medical Systems has higher revenue and earnings than CONMED. CONMED is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.37B	0.96	$47.06M	$1.77	24.65
Merit Medical Systems	$1.52B	2.96	$128.49M	$2.31	32.61

Summary

Merit Medical Systems beats CONMED on 13 of the 16 factors compared between the two stocks.

How does CONMED compare to LivaNova?

LivaNova (NASDAQ:LIVN) and CONMED (NYSE:CNMD) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations.

LivaNova has a beta of 0.86, meaning that its stock price is 14% less volatile than the broader market. Comparatively, CONMED has a beta of 0.93, meaning that its stock price is 7% less volatile than the broader market.

In the previous week, CONMED had 8 more articles in the media than LivaNova. MarketBeat recorded 9 mentions for CONMED and 1 mentions for LivaNova. LivaNova's average media sentiment score of 0.72 beat CONMED's score of 0.17 indicating that LivaNova is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LivaNova	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CONMED	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

97.6% of LivaNova shares are owned by institutional investors. 0.4% of LivaNova shares are owned by insiders. Comparatively, 0.3% of CONMED shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

CONMED has lower revenue, but higher earnings than LivaNova. CONMED is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LivaNova	$1.39B	3.18	-$242.47M	$1.95	41.26
CONMED	$1.37B	0.96	$47.06M	$1.77	24.65

LivaNova has a net margin of 7.48% compared to CONMED's net margin of 4.00%. LivaNova's return on equity of 16.48% beat CONMED's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LivaNova	7.48%	16.48%	7.59%
CONMED	4.00%	13.84%	6.05%

LivaNova currently has a consensus price target of $81.38, indicating a potential upside of 1.13%. CONMED has a consensus price target of $38.80, indicating a potential downside of 11.09%. Given LivaNova's stronger consensus rating and higher possible upside, research analysts clearly believe LivaNova is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LivaNova	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
CONMED	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.63

Summary

LivaNova beats CONMED on 13 of the 16 factors compared between the two stocks.

How does CONMED compare to MiniMed Group?

CONMED (NYSE:CNMD) and MiniMed Group (NASDAQ:MMED) are both medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends.

In the previous week, MiniMed Group had 4 more articles in the media than CONMED. MarketBeat recorded 13 mentions for MiniMed Group and 9 mentions for CONMED. CONMED's average media sentiment score of 0.17 beat MiniMed Group's score of 0.15 indicating that CONMED is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	12 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

19.7% of MiniMed Group shares are owned by institutional investors. 0.3% of CONMED shares are owned by insiders. Comparatively, 2.2% of MiniMed Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

CONMED currently has a consensus price target of $38.80, suggesting a potential downside of 11.09%. MiniMed Group has a consensus price target of $21.33, suggesting a potential upside of 24.79%. Given MiniMed Group's stronger consensus rating and higher possible upside, analysts clearly believe MiniMed Group is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.63
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.73

CONMED has a net margin of 4.00% compared to MiniMed Group's net margin of 0.00%. CONMED's return on equity of 13.84% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	4.00%	13.84%	6.05%
MiniMed Group	N/A	N/A	N/A

CONMED has higher earnings, but lower revenue than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.37B	0.96	$47.06M	$1.77	24.65
MiniMed Group	$3.10B	1.55	-$190.97M	-$0.68	N/A

Summary

MiniMed Group beats CONMED on 8 of the 15 factors compared between the two stocks.

How does CONMED compare to Envista?

Envista (NYSE:NVST) and CONMED (NYSE:CNMD) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations and media sentiment.

CONMED has a net margin of 4.00% compared to Envista's net margin of 2.41%. CONMED's return on equity of 13.84% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
CONMED	4.00%	13.84%	6.05%

Envista presently has a consensus target price of $28.54, indicating a potential upside of 6.55%. CONMED has a consensus target price of $38.80, indicating a potential downside of 11.09%. Given Envista's stronger consensus rating and higher possible upside, equities research analysts clearly believe Envista is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38
CONMED	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.63

Envista has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market. Comparatively, CONMED has a beta of 0.93, meaning that its share price is 7% less volatile than the broader market.

CONMED has lower revenue, but higher earnings than Envista. CONMED is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.60	$47M	$0.41	65.33
CONMED	$1.37B	0.96	$47.06M	$1.77	24.65

In the previous week, CONMED had 8 more articles in the media than Envista. MarketBeat recorded 9 mentions for CONMED and 1 mentions for Envista. Envista's average media sentiment score of 1.02 beat CONMED's score of 0.17 indicating that Envista is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CONMED	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Envista and CONMED tied by winning 7 of the 14 factors compared between the two stocks.

How does CONMED compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and CONMED (NYSE:CNMD) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership, risk and media sentiment.

CONMED has a net margin of 4.00% compared to iRhythm Technologies' net margin of -3.53%. CONMED's return on equity of 13.84% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
CONMED	4.00%	13.84%	6.05%

iRhythm Technologies has a beta of 1.27, suggesting that its share price is 27% more volatile than the broader market. Comparatively, CONMED has a beta of 0.93, suggesting that its share price is 7% less volatile than the broader market.

In the previous week, iRhythm Technologies had 1 more articles in the media than CONMED. MarketBeat recorded 10 mentions for iRhythm Technologies and 9 mentions for CONMED. iRhythm Technologies' average media sentiment score of 0.27 beat CONMED's score of 0.17 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	2 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
CONMED	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

iRhythm Technologies presently has a consensus target price of $186.62, indicating a potential upside of 66.85%. CONMED has a consensus target price of $38.80, indicating a potential downside of 11.09%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts clearly believe iRhythm Technologies is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
CONMED	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.63

CONMED has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	4.92	-$44.55M	-$0.86	N/A
CONMED	$1.37B	0.96	$47.06M	$1.77	24.65

Summary

iRhythm Technologies beats CONMED on 8 of the 15 factors compared between the two stocks.

Get CONMED News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CNMD vs. The Competition

Export

Metric	CONMED	MED/DENTAL Industry	Medical Sector	NYSE Exchange
Market Cap	$1.31B	$16.75B	$6.82B	$23.33B
Dividend Yield	N/A	1.32%	2.67%	4.16%
P/E Ratio	24.62	19.30	27.14	30.82
Price / Sales	0.96	2.32	574.10	20.84
Price / Cash	6.00	14.30	29.05	18.80
Price / Book	1.31	3.29	10.67	4.75
Net Income	$47.06M	$534.24M	$3.59B	$1.06B
7 Day Performance	2.74%	-0.62%	-1.65%	-0.01%
1 Month Performance	33.91%	5.69%	1.01%	0.94%
1 Year Performance	-8.36%	3.99%	24.41%	16.76%

CONMED Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CNMD CONMED	1.9791 of 5 stars	$43.64 +1.0%	$38.80 -11.1%	-9.6%	$1.31B	$1.37B	24.62	3,900	News Coverage Analyst Upgrade
MMSI Merit Medical Systems	4.2254 of 5 stars	$73.26 -0.2%	$92.80 +26.7%	-10.9%	$4.38B	$1.52B	31.71	7,500	Positive News
LIVN LivaNova	1.6108 of 5 stars	$82.98 +0.5%	$80.75 -2.7%	+92.2%	$4.54B	$1.39B	42.55	3,300	Positive News
MMED MiniMed Group	2.5404 of 5 stars	$16.10 +5.3%	$21.33 +32.5%	N/A	$4.52B	$3.10B	N/A	8,000	News Coverage
NVST Envista	2.3615 of 5 stars	$26.23 +1.2%	$28.54 +8.8%	+37.3%	$4.22B	$2.72B	63.97	12,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CNMD) was last updated on 7/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CONMED (CNMD) Competitors

CNMD vs. MMSI, LIVN, MMED, NVST, and IRTC

How does CONMED compare to Merit Medical Systems?

Summary

How does CONMED compare to LivaNova?

Summary

How does CONMED compare to MiniMed Group?

Summary

How does CONMED compare to Envista?

Summary

How does CONMED compare to iRhythm Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNMD vs. The Competition

CONMED Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CONMED (CNMD) Competitors

CNMD vs. MMSI, LIVN, MMED, NVST, and IRTC

How does CONMED compare to Merit Medical Systems?

Is CNMD or MMSI more profitable?

Do analysts recommend CNMD or MMSI?

Do insiders and institutionals have more ownership in CNMD or MMSI?

Which has more volatility & risk, CNMD or MMSI?

Does the media favor CNMD or MMSI?

Which has higher earnings & valuation, CNMD or MMSI?

Summary

How does CONMED compare to LivaNova?

Which has more volatility and risk, LIVN or CNMD?

Does the media favor LIVN or CNMD?

Do institutionals & insiders have more ownership in LIVN or CNMD?

Which has better valuation & earnings, LIVN or CNMD?

Is LIVN or CNMD more profitable?

Do analysts rate LIVN or CNMD?

Summary

How does CONMED compare to MiniMed Group?

Does the media favor CNMD or MMED?

Do institutionals and insiders hold more shares of CNMD or MMED?

Do analysts prefer CNMD or MMED?

Is CNMD or MMED more profitable?

Which has better earnings and valuation, CNMD or MMED?

Summary

How does CONMED compare to Envista?

Is NVST or CNMD more profitable?

Do analysts prefer NVST or CNMD?

Which has more volatility & risk, NVST or CNMD?

Which has better earnings & valuation, NVST or CNMD?

Does the media favor NVST or CNMD?

Summary

How does CONMED compare to iRhythm Technologies?

Is IRTC or CNMD more profitable?

Which has more volatility & risk, IRTC or CNMD?

Does the media prefer IRTC or CNMD?

Do analysts rate IRTC or CNMD?

Which has better valuation & earnings, IRTC or CNMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNMD vs. The Competition

CONMED Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools